FR2896164B1 - Formulation colloidale d'insuline longue action et sa preparation - Google Patents

Formulation colloidale d'insuline longue action et sa preparation

Info

Publication number
FR2896164B1
FR2896164B1 FR0650183A FR0650183A FR2896164B1 FR 2896164 B1 FR2896164 B1 FR 2896164B1 FR 0650183 A FR0650183 A FR 0650183A FR 0650183 A FR0650183 A FR 0650183A FR 2896164 B1 FR2896164 B1 FR 2896164B1
Authority
FR
France
Prior art keywords
preparation
long
acting insulin
colloidal formulation
colloidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0650183A
Other languages
English (en)
Other versions
FR2896164A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamel Technologies SA
Original Assignee
Flamel Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamel Technologies SA filed Critical Flamel Technologies SA
Priority to FR0650183A priority Critical patent/FR2896164B1/fr
Priority to PCT/EP2007/000335 priority patent/WO2007082712A1/fr
Publication of FR2896164A1 publication Critical patent/FR2896164A1/fr
Priority to US11/907,039 priority patent/US20080175921A1/en
Application granted granted Critical
Publication of FR2896164B1 publication Critical patent/FR2896164B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR0650183A 2006-01-18 2006-01-18 Formulation colloidale d'insuline longue action et sa preparation Expired - Fee Related FR2896164B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0650183A FR2896164B1 (fr) 2006-01-18 2006-01-18 Formulation colloidale d'insuline longue action et sa preparation
PCT/EP2007/000335 WO2007082712A1 (fr) 2006-01-18 2007-01-16 Formulation colloïdale d'insuline longue action et sa préparation
US11/907,039 US20080175921A1 (en) 2006-01-18 2007-10-09 Colloidal formulation of long-acting insulin and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0650183A FR2896164B1 (fr) 2006-01-18 2006-01-18 Formulation colloidale d'insuline longue action et sa preparation

Publications (2)

Publication Number Publication Date
FR2896164A1 FR2896164A1 (fr) 2007-07-20
FR2896164B1 true FR2896164B1 (fr) 2008-07-04

Family

ID=36940671

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0650183A Expired - Fee Related FR2896164B1 (fr) 2006-01-18 2006-01-18 Formulation colloidale d'insuline longue action et sa preparation

Country Status (3)

Country Link
US (1) US20080175921A1 (fr)
FR (1) FR2896164B1 (fr)
WO (1) WO2007082712A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9060927B2 (en) * 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2961374A (en) * 1950-10-14 1960-11-22 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
FR2732218B1 (fr) * 1995-03-28 1997-08-01 Flamel Tech Sa Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation
FR2801226B1 (fr) * 1999-11-23 2002-01-25 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation
FR2814952B1 (fr) * 2000-10-06 2004-01-02 Flamel Tech Sa Suspension colloidale de particules submicromiques de vectorisation de principes actifs et leur mode de preparation
FR2873040B1 (fr) * 2004-07-19 2007-11-30 Flamel Technologies Sa Formulation colloidale d'insuline longue action et sa preparation

Also Published As

Publication number Publication date
FR2896164A1 (fr) 2007-07-20
WO2007082712A1 (fr) 2007-07-26
US20080175921A1 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
SMT201500176B (it) Composizioni e metodi per inibire l'espressione ditranstiretina
GB2457207B (en) Smart actuation materials triggered by degradation in oilfield environments and methods of use
BRPI0722062A2 (pt) Anticorpos contra receptor do fator de crescimento i semelhante à insulina e usos dos mesmos
SI2001903T1 (sl) Dolgo delujoäťi polipeptidi in metode za izdelavo in dajanje le-teh
ZA200702262B (en) Personal care compositions with glycerin and hydroxypropyl quaternary ammonium salts
IL199444A0 (en) Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
EP2021555A4 (fr) Élément structurel et procédés d'utilisation associés
EP2068841A4 (fr) Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations
DE602006016014D1 (de) Kombination aus triazinderivaten und insulin-sensibilisatoren
BRPI0907706A2 (pt) Composto, uso do dito composto e composição farmacéutica compreendendo o dito composto
BRPI0719228A2 (pt) Composição estabilizada de prostaglandina e
ITMI20051416A1 (it) Composizioni cosmetiche contenenti acido ialuronico e colostro
FR2915325B1 (fr) Structure d'engagement de connecteurs
IL195493A0 (en) Combination preparations comprising bifeprunox and l-dopa
FR2896164B1 (fr) Formulation colloidale d'insuline longue action et sa preparation
PL2018102T3 (pl) Kompozycja środka odstraszającego owady do miejscowego stosowania i sposoby jego nanoszenia
GB0614024D0 (en) Improvements in and relating to headboards
ITMI20061522A1 (it) Composizione ad attivita' antiossidante ed antiglicante migliorata
ITRM20070681A1 (it) Composizione liposomiale di colistina per uso terapeutico endovenoso orale e cutaneo
ITVR20050093A1 (it) Iniettore particolarmente conformato da utilizzare preferibilmente ma non limitatamente per il consolidamento e l'impermeabilizzazione di murature e procedimento per il suo utilizzo.
UA14311S (uk) Набір м'яких меблів «венеція»
UA13337S (uk) Набір м'яких меблів «філ»
GB0615494D0 (en) Improved sunscreen formulation and means of application thereof
UA14267S (uk) Боковина опорна крісел і диванів

Legal Events

Date Code Title Description
RN Application for restoration
FC Decision of inpi director general to approve request for restoration
ST Notification of lapse

Effective date: 20120928